
Collaboration with Europe’s leading university hospital provides access to the widest possible range of diagnostic and imaging technologies. Allied with the support of the associated therapeutic area experts, such technologies can readily and seamlessly be integrated into very early clinical studies – including FTIH studies. There, they can be used to provide enhanced safety data and facilitate the exploration and visualization of sub-clinical efficacy. From the assessment of Flow Mediated Dilation to 7-tesla MRI imaging, working with one of the largest and very best financed university hospitals in Europe ensures access to the very latest technologies.
Look for Early Improvement
Ultrasound used to look for early improvement of synovitis in a FTIH study in 58 RA patients, combining SAD & MAD dosing in a semi-parallel design with a single-center approach.
Access to the widest range of cutting edge diagnostic and imaging technologies which are typically only available via specialized medical centers
No scheduling or access issues, with some equipment set-ups already dedicated to research use
Internalization of key diagnostic equipment used in common studies